尿道感染检测市场规模、份额和成长分析（检测套组、感染类型、检测类型、最终用户和地区）- 产业预测 2025-2032

2023 年全球尿道感染检测市场规模为 6.102 亿美元，预计将从 2024 年的 6.3827 亿美元成长到 2032 年的 9.1466 亿美元，预测期内（2025-2032 年）的复合年增长率为 4.6%。

受诊断技术的进步以及人们对主要影响女性的泌尿道感染 ( 尿道感染)的认识不断提高的推动，全球尿道感染(UTI) 检测市场有望成长。主要驱动因素包括尿道结石盛行率上升、医疗支出增加以及人口老化使人们更容易受到这些感染疾病。诊断工具的创新，包括即时诊断和无创技术，正在改善早期检测和管理。个人化和预防医疗的转变进一步推动了先进诊断解决方案的采用。然而，某些测试方法的准确性和替代疗法的竞争等挑战可能会抑製成长。总体而言，由于感染疾病控制仍然是医疗保健的首要任务，预计未来几年尿道结石检测市场将稳定扩大。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

尿道感染检测市场规模（检测套组及复合年增长率划分）（2025-2032）

• 市场概况
• 家庭检测套组
• 临床检测套组

尿道感染检测市场规模（依感染类型及复合年增长率）（2025-2032）

• 市场概况
• 尿道炎
• 膀胱炎
• 肾盂肾炎

尿道感染检测市场规模（按检测类型和复合年增长率） (2025-2032)

• 市场概况
• 尿液检查
• 尿液培养
• 药敏试验

尿道感染检测市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 全科医生（GP）
• 泌尿系统
• 泌尿系统- 妇科医生
• 医院检查室
• 参考实验室
• 医院急诊部
• 紧急护理
• 其他的

尿道感染检测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Becton, Dickinson and Company（BD）（USA）
• bioMerieux SA（France）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Bio-Rad Laboratories, Inc.（USA）
• Cepheid（USA）（Parent Company：Danaher Corporation）
• Hologic, Inc.（USA）
• Quidel Corporation（USA）
• Meridian Bioscience, Inc.（USA）
• Luminex Corporation（USA）
• QIAGEN NV（Netherlands）
• Beckman Coulter, Inc.（USA）（Parent Company：Danaher Corporation）
• Sysmex Corporation（Japan）
• OraSure Technologies, Inc.（USA）
• GenMark Diagnostics, Inc.（USA）
• Mesa Biotech, Inc.（USA）
• Alere Inc.（USA）（Parent Company：Abbott Laboratories）
• T2 Biosystems, Inc.（USA）

结论和建议

Global Urinary Tract Infection Testing Market size was valued at USD 610.2 million in 2023 and is poised to grow from USD 638.27 million in 2024 to USD 914.66 million by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The global urinary tract infection (UTI) testing market is poised for growth, fueled by advancements in diagnostic technology and increasing awareness of UTIs, which predominantly affect women. Key drivers include a rising incidence of UTIs, elevated healthcare spending, and an aging population more vulnerable to these infections. Innovations in diagnostic tools, such as point-of-care tests and non-invasive methodologies, are improving early detection and management. The shift towards personalized and preventive healthcare further propels the adoption of sophisticated diagnostic solutions. However, challenges like the accuracy of certain testing methods and competition from alternative treatments may temper growth. Overall, as infection management remains a priority in healthcare, the UTI testing market is expected to experience steady expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinary Tract Infection Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinary Tract Infection Testing Market Segments Analysis

Global Urinary Tract Infection Testing Market is segmented by Test Kit, Infection Type, Test Type, End User and region. Based on Test Kit, the market is segmented into Home Test Kits and Laboratory Test Kits. Based on Infection Type, the market is segmented into Urethritis, Cystitis and Pyelonephritis. Based on Test Type, the market is segmented into Urinalysis, Urine Cultures and Susceptibility Testing. Based on End User, the market is segmented into General Practitioners (GPs), Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is profoundly impacted by the rising incidence of antibiotic-resistant UTIs. The improper utilization and overprescription of antibiotics have resulted in the development of resistant bacterial strains, complicating UTI treatment strategies. This critical issue has heightened the demand for precise diagnostic methods, including urine cultures and susceptibility tests, which aid healthcare professionals in identifying effective treatments based on specific bacteria. Furthermore, the pressing need to address antibiotic resistance has led to increased investment in research for innovative therapies. This ongoing development is driving the market towards advanced solutions aimed at managing resistant UTIs while encouraging responsible antibiotic usage.

Restraints in the Global Urinary Tract Infection Testing Market

Antibiotic resistance is a major challenge impacting the global urinary tract infection (UTI) testing market. The excessive and improper use of antibiotics has resulted in the rise of drug-resistant bacteria, diminishing the effectiveness of standard treatments for UTIs. This issue complicates the management of these infections, leading to longer recovery times, escalating healthcare expenses, and a risk of severe complications for patients. Healthcare professionals must carefully balance the necessity for effective treatment against the prudent use of antibiotics to address this pressing issue. As a result, there is an increasing demand for innovative diagnostic methods and alternative treatment strategies within the UTI market.

Market Trends of the Global Urinary Tract Infection Testing Market

The global urinary tract infection (UTI) testing market is experiencing a significant shift towards Point-of-Care (POC) testing methods, driven by the need for prompt and precise diagnostics. POC tests are increasingly favored due to their ability to deliver rapid results and allow for on-site testing, thus minimizing reliance on centralized laboratories and decreasing turnaround times. This trend caters to rising consumer demands for efficient UTI diagnosis, particularly in primary healthcare environments. As innovations in technology further enhance the accuracy and efficiency of these tests, their integration into routine clinical practice is transforming UTI diagnostics and ultimately improving patient care outcomes worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Urinary Tract Infection Testing Market Size by Test Kit & CAGR (2025-2032)

• Market Overview
• Home Test Kits
• Laboratory Test Kits

Global Urinary Tract Infection Testing Market Size by Infection Type & CAGR (2025-2032)

• Market Overview
• Urethritis
• Cystitis
• Pyelonephritis

Global Urinary Tract Infection Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Urinalysis
• Urine Cultures
• Susceptibility Testing

Global Urinary Tract Infection Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• General Practitioners (GPs)
• Urologists
• Urogynecologists
• Hospital Laboratories
• Reference Laboratories
• Hospital Emergency Departments
• Urgent Care
• Others

Global Urinary Tract Infection Testing Market Size & CAGR (2025-2032)

• North America (Test Kit, Infection Type, Test Type, End User)
  • US
  • Canada
• Europe (Test Kit, Infection Type, Test Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Kit, Infection Type, Test Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Kit, Infection Type, Test Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Kit, Infection Type, Test Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA) (Parent Company: Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA) (Parent Company: Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesa Biotech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA) (Parent Company: Abbott Laboratories)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations